SAY COMMUNICATIONS LUGANO, 30 September, 2021 – A new study has found that a direct-to-consumer machine learning model for detecting skin cancers incorrectly classified rare and aggressive cancers as low-risk.1 The breakthrough findings presented at today’s 30th EADV Congress suggest that making apps based on such models available directly to the public without transparency on performance metrics for...
Month: <span>September 2021</span>
Post
Researchers Discover Unknown Childhood Genetic Condition and its Potential Cure
Describing a previously unknown genetic condition that affects children, researchers at University of California San Diego School of Medicine and Rady Children’s Institute for Genomic Medicine say they also found a potential method to prevent the gene mutation by administering a drug during pregnancy. The findings were published in the journal The New England Journal of...
Post
Further evidence that vitamin D might protect against severe COVID-19 disease and death
New research from Trinity College and University of Edinburgh has examined the association between vitamin D and COVID-19, and found that ambient ultraviolet B (UVB) radiation (which is key for vitamin D production in the skin) at an individual’s place of residence in the weeks before COVID-19 infection, was strongly protective against severe disease and...
Post
New Treatment for Inflammatory Bowel Disease: Opioids May Cure that “Bad Gut Feeling”
Opioid receptors play key roles in regulating our senses and emotions. Recently, their discovery outside the nervous system raised several questions about the effects of opioids on the immune system. Now, researchers from Japan have shown that KNT-127—a drug that targets delta opioid receptors—can reduce pro-inflammatory signals in the colon. Their research highlights the immunomodulatory...
Post
NANOG Expression versus Cellular Senescence
Are there many strategies that can reverse cellular senescence? There are certainly strategies that can lower levels of cellular senescence over time, both in cell cultures and in living animals, but very few are actually reprogramming senescent cells into normal cells. It isn’t clear that this reversal of the senescent state is a good idea,...
Post
New nanomaterial for treatment of skin infections
INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY OF THE CZECH ACADEMY OF SCIENCES (IOCB PRAGUE) IMAGE: DR. DOMINIK REJMAN, HEAD OF THE ANTIMICROBIAL COMPOUNDS GROUP AT IOCB PRAGUE (CZECH REPUBLIC). HTTPS://REJMAN.GROUP.UOCHB.CZ CREDIT: PHOTO: TOMÁŠ BELLOŇ / IOCB PRAGUE Researchers at the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague) and the Technical University...
Post
Safer treatment for deep-seated tumors
UNIVERSITY OF TEXAS AT ARLINGTON IMAGE: WEI CHEN, PROFESSOR OF PHYSICS, THE UNIVERSITY OF TEXAS AT ARLINGTON CREDIT: ERIKA SUAREZ/UTA Wei Chen, professor of physics at The University of Texas at Arlington, is the senior author of two papers detailing the effects of copper cysteamine, a next-generation cancer photodrug invented in Chen’s laboratory. The first...
Post
UCLA bioengineers develop new class of human-powered bioelectronics
UNIVERSITY OF CALIFORNIA – LOS ANGELES IMAGE: UCLA-DESIGNED SELF-POWERED, STRETCHABLE, WATERPROOF MAGNETOELASTIC GENERATOR FOR BIOELECTRONICS. CREDIT: JUN CHEN/UCLA A team of bioengineers at the UCLA Samueli School of Engineering has invented a novel soft and flexible self-powered bioelectronic device. The technology converts human body motions — from bending an elbow to subtle movements such as...
Post
Gene found in monkeys and mice could work as a new type of antiviral to block HIV, Ebola, and other deadly viruses in humans
UNIVERSITY OF UTAH HEALTH A nationwide team of researchers, led by scientists at University of Utah Health and The Rockefeller University, has determined how a genetic mutation found in mice and monkeys interferes with viruses such as HIV and Ebola. They say the finding could eventually lead to the development of medical interventions in humans. The gene,...
Post
New nanoparticle developed for intravenous cancer immunotherapy
UNIVERSITY OF MICHIGAN Cancer immunotherapy seeks to turn “cold” tumors into “hot” tumors––those that respond to immunotherapy––by awakening and enlisting the body’s own immune system. Unfortunately, few people benefit from the most common form of immunotherapy, called immune checkpoint inhibitors, and scientists are actively seeking new and safe molecules called agonists to augment the body’s...